Navigation Links
Timeliness, a Critical Factor in Treating TTTS

dure to treat the anatomic basis for the syndrome. Until now, the only major study comparing these two treatments for TTTS was the Eurofetus trial, which compared laser and amnioreduction as primary therapies. That study, published in The New England Journal of Medicine in 2004, found that, at six months, there was better survival among twins using laser vs. amnioreduction.

The NIH-funded study, which began in 2002, required participants to have more severe disease and to have already failed an initial amnioreduction. But when the Eurofetus results were published, everyone thought that laser was superior and stopped referring patients. The American investigators asked that the trial be stopped. Unbeknownst to investigators at that time, the trial oversight committee found significant differences between the two treatment modalities and recommended that the trial be stopped, which it was in May of 2005.

The trial had uncovered higher mortality among recipient twins who received laser treatment. But overall, survival of one or both twins of the same pregnancy was no different between the two treatments. In addition, there was no difference between survival rates of donor twins and recipient twins. How is this possible?

"It turns out that in amnioreduction, there were significant numbers of treatment failures, so patients were dropping out in the amnioreduction arm because they were failing therapy, whereas they were dying in the laser therapy," says Dr. Crombleholme. Statistically, these patients are considered to have had the same outcome: a treatment failure. So, ultimately, there was no significant difference in survival of one or both twins between the two treatments."

What Dr. Crombleholme and his colleagues did find were two predictors of success. One was the stage of severity of TTTS. The other was the echocardiographic finding of heart failure. Fetal echocardiography, which is not done routinely in TTTS in most c
'"/>




Page: 1 2 3

Related medicine news :

1. Ultrasound Screening Could Improve The Outcome Of Critically ill Patients
2. Sleep Not Critical For Early Brain Development Of Baby Dolphins
3. Critically Ill Patients More At Risk Of Infection If Glucose Is Present In Their Lung Secretions
4. Dietary supplementation of Folic Acid Requires Critical Evaluation
5. Past President Narayanans Condition Still Critical
6. Critical Decisions Have To Be Taken By Mothers Of Premature Babies
7. Heart Transplant Twin Recovering, But Brother Critical
8. Australia In Search Of A Better Way to Handle Critically Ill Patients and Balance Elective Surgery
9. Yeast Genome Unravels Genes Critical For Maintaining DNA Integrity
10. Drug Trial Goes Foul, Six Volunteers Critically Ill
11. Sensory Input Necessary During "Critical Periods" Of Brain Development
Post Your Comments:
(Date:7/9/2008)...etic outcome after lumpectomy linked to depression...9 (HealthDay News) -- A third of women who opt for...e an asymmetry between their breasts that greatly ..., Women whose affected breast looked noticeably ...ar their cancer returning and to have symptoms of ...
(Date:7/9/2008)...ship Integrates In-Store and Online Marketing to C...erience, PITTSBURGH and NEW YORK, July 9 /PRNewsw..."GNC"), the largest global specialty retailer of,n...he leading source of,health information, today ann...ase consumer awareness and understanding of the im...
(Date:7/9/2008)...LAS and PLANO, Texas, July 9 /PRNewswire/ -- SKINT... is pleased to announce the arrival,of newly FDA-a...gen filler,in the Skintastic arsenal of little-or-...s immediate, predictable visible results, with lit...orted with EVOLENCE(R) in a,comparison study again...
(Date:7/9/2008)... DRE, Inc., a premier international...its customers that as much as $250,000 in medical ...me tax filings. , Louisvi...lus Act of 2008, in accordance with Tax Code Secti... equipment bought in 2008. This could make 2008 an...
Breaking Medicine News(10 mins):Health News:Breast-Conserving Surgery Leaves Many Cancer Patients Disappointed 2Health News:GNC and WebMD Announce Agreement To Provide Consumers with Health and Nutritional Information While Promoting the Benefits of a Healthy Lifestyle 2Health News:GNC and WebMD Announce Agreement To Provide Consumers with Health and Nutritional Information While Promoting the Benefits of a Healthy Lifestyle 3Health News:New Injectable Collagen Filler Offers Natural Results 2Health News:Economic Stimulus Act Can Improve Medical Equipment Purchasing Power 2
...ongly condemned the UPA-Left decision to introduce...tack' on meritorious// students deserving a berth ...protesting students at Chittaranjan National Medic...s will hold a massive demonstration against the Ce...
...lihood of a woman suffering from domestic violence...n the emergency department about the topic. This a...ealth problem would be stressed, reveals a study, ...ne, (May 22) JAMA/Archives journals. Reluctance to...
...ith metabolic syndrome are significantly more like...ults of a new study indicate//. Metabolic syndrom..., high blood pressure and low levels of 'good' (HD...drome is at an increased risk of developing corona...
...orld Health Organization, Dr Lee Jong-Wook, is a m...alth Organization (India) said here today.// Lee, ... and other deadly diseases, was the first WHO chie...ng as DG, PHO general secretary I S Gilada said. P...
Other Medicine News:Health News:Discussion On Domestic Violence Increased By Computer Based Screening 2Health News:Discussion On Domestic Violence Increased By Computer Based Screening 3
(Date:7/7/2008)...Newswire-FirstCall/ -- Pulmo BioTech Inc. (OTC,Bul...diary, PulmoScience,Inc. has completed the bio-dis...for the PulmoBind technology of Molecular Imaging ...maging uses a molecule designed to bond specifical...lmoBind, the chosen molecule,was designed to bond ...
(Date:7/7/2008)...ewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC,Bulle...d biopharmaceutical,company specializing in the pr...ay provided an operational update on the company,s...man clinical trial testing and,plans to proceed in... Five,successful human trials evaluating GeoVax AI...
(Date:7/7/2008)...July 7 /- The Leukemia & Lymphoma,Soc...dberg M.D., M.M.Sc.,of the James P. Wilmot Cancer...ter. Millennium Pharmaceuticals, The Takeda Oncolo...rst two years of the five-year program., The Scho...will support,Dr. Friedberg,s work on a new targete...
(Date:7/6/2008)...TI,s Marketing Authorization Application currently... SEATTLE, July 7 /- Cell Th... announced the publication of results from its,ran...itaxel poliglumex,CT-2103) with gemcitabine or vi...tatus 2) patients with previously untreated non-sm...
Breaking Medicine Technology:Pulmo BioTech Inc. Completes Bio-Distribution Studies 2Pulmo BioTech Inc. Completes Bio-Distribution Studies 3GeoVax Reports Progress on Its AIDS Vaccine Technology 2GeoVax Reports Progress on Its AIDS Vaccine Technology 3GeoVax Reports Progress on Its AIDS Vaccine Technology 4GeoVax Reports Progress on Its AIDS Vaccine Technology 5University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society 2Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 2Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 3Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 4Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 5A search for protection against chemotherapy cardiotoxicity 1693 1A search for protection against chemotherapy cardiotoxicity 1693 2Certain diseases birth defects may be linked to failure of protein recycling system 1691 1Certain diseases birth defects may be linked to failure of protein recycling system 1691 2Center for Consumer Freedom Releases Dont Sue Me Santa Christmas Cookie Liability Waiver 8633 1Center for Consumer Freedom Releases Dont Sue Me Santa Christmas Cookie Liability Waiver 8633 2ZONARE Ranked Best in KLAS as Hand Carried Ultrasound Vendor in 2007 Top20 3A Year End Report 8631 1ZONARE Ranked Best in KLAS as Hand Carried Ultrasound Vendor in 2007 Top20 3A Year End Report 8631 2ZONARE Ranked Best in KLAS as Hand Carried Ultrasound Vendor in 2007 Top20 3A Year End Report 8631 3
...007 - Medtronic, Inc.,(NYSE:MDT) today announced ...l Trial indicates that the trial has met its prima...nical Trial is a randomized, single-blind,trial ev...M) Drug,Eluting Coronary Stent as compared to the ...m Boston Scientific Corporation,(NYSE:BSX). ENDEAV...
...rget from Lexicon,s Genetic,Research -, THE WOODLA...-,Lexicon Pharmaceuticals, Inc. today reported res...antibodies directed to a,potential new target, ang...triglycerides and cholesterol. Research suggests t...may have therapeutic,application in the treatment ...
Other Medicine Technology:ENDEAVOR IV Clinical Trial Meets Primary Endpoint 2Lexicon Develops Antibodies That Lower Triglycerides and,Cholesterol as Potential New Therapy for Heart Disease 2Lexicon Develops Antibodies That Lower Triglycerides and,Cholesterol as Potential New Therapy for Heart Disease 3Lexicon Develops Antibodies That Lower Triglycerides and,Cholesterol as Potential New Therapy for Heart Disease 4Lexicon Develops Antibodies That Lower Triglycerides and,Cholesterol as Potential New Therapy for Heart Disease 5
Full Handle Laseredge Stab Blade Knife, 22.5 blade. Blade tip dimension: 10.7 mm x 1.8 mm x 4.2 mm.
19 Gauge. Reusable. Block of 4 each.
18 gauge curved. Fine tip. Lightweight design offers precise hemostasis. Pencil design minimizes tissue trauma and induced astigmatism. Knurled handle provides a sure grip and better manipulation.
Set consist of two 23 gauge, stainless steel probes with blunt tips. Probes are 18 cm (7.0 inches) long with 30.5 cm (12 inches) of flexible tubing (O.D. - 0.60 mm, I.D. - 0.30 mm) attached onto the
Medicine Products: